Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

NHS prescription charges in England to be frozen for first time in 12 years

May 16, 2022 Sales and Marketing

The Department of Health has said that single prescription charges, which normally rise “in line with inflation”, will remain at …
News

Imfimzi for routine use on NHS England for patients with stage III unresectable lung cancer

May 16, 2022 Sales and Marketing

AstraZeneca has announced the NICE recommendation of Imfinzi (durvalumab) for routine use within NHS England as a monotherapy for the …
News

Researchers pinpoint reason for Sudden Infant Deaths

May 16, 2022 Sales and Marketing

Scientists from The Children’s Hospital Westmead in Sydney have discovered that babies who died of sudden infant death syndrome (SIDS) …
News

Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi

May 9, 2022 Sales and Marketing

Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium …
News

FDA places partial clinical hold on BioCryst’s lead candidate, BCX9930

May 9, 2022 Sales and Marketing

The FDA has imposed a partial clinical hold on BioCryst’s Factor D inhibitor, BCX9930. The clinical hold arrives around a …
News

Case of monkeypox confirmed in England

May 9, 2022 Sales and Marketing

The UK Health Security Agency has confirmed that a person in England has been diagnosed with the monkeypox virus.The patient …
News

New data for Shionogi’s COVID-19 antiviral show rapid virus clearance

April 25, 2022 Sales and Marketing

Shionogi has announced new results from two late-breaking presentations of S-217622. This is an investigational 3CL protease inhibitor that was …
News

National shortage of HRT medication due to high demand

April 25, 2022 Sales and Marketing

The national shortage of HRT products could have an impact on some women, who may not be able to sleep …
News

EMA recommend new treatment option for severe postpartum haemorrhage

April 25, 2022 Sales and Marketing

Novo Nordisk has announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion …
News

Ukraine: crisis for people with chronic diseases

April 25, 2022 Sales and Marketing

Preliminary results from an ongoing nationwide health needs assessment, conducted by WHO in partnership with Premise, indicate that one in …
News

Recipharm announces closing of acquisitions of two major CDMOs

April 11, 2022 Sales and Marketing

Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisitions …
News

Innovative therapy ‘tricks’ and destroys cancer cells

April 11, 2022 Sales and Marketing

A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …
News

World leaders pledge $4.8 billion in 2022 Break COVID Now Summit

April 11, 2022 Sales and Marketing

World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …
News

‘Killer’ immunotherapy shows early promise

April 11, 2022 Sales and Marketing

A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range …
News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025